GH Guardant Health, Inc.
Healthcare$119.85+0.76%ClosedMarket Cap: $15.89B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-86.24
P/S
14.60
EV/EBITDA
-42.10
DCF Value
$-223.03
FCF Yield
-1.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
64.9%
Operating Margin
-41.4%
Net Margin
-40.1%
ROE
184.3%
ROA
-22.6%
ROIC
-27.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $301.7M | 65.2% | $-121.3M | $-112.1M | $— | — |
| Q4 null | $281.3M | 64.6% | $-120.8M | $-128.5M | $— | — |
| FY null | $982.0M | 64.5% | $-436.3M | $-416.3M | $— | — |
| Q3 null | $265.2M | 64.7% | $-99.0M | $-92.7M | $— | — |
| Q2 null | $232.1M | 65.0% | $-106.4M | $-99.9M | $— | — |
| Q1 null | $203.5M | 63.3% | $-111.0M | $-95.2M | $— | — |
| Q4 null | $201.8M | 61.6% | $-126.0M | $-111.0M | $— | — |
| FY null | $739.0M | 60.8% | $-443.6M | $-436.4M | $— | — |
| Q3 null | $191.5M | 61.1% | $-117.3M | $-107.8M | $— | — |
| Q2 null | $177.2M | 59.1% | $-100.6M | $-102.6M | $— | — |
| Q1 null | $168.5M | 61.2% | $-99.7M | $-115.0M | $— | — |
| Q4 2023 | $155.1M | 152.3% | $-197.5M | $-187.0M | $-1.58 | — |